Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Dec 18;60(24):2465-72.
doi: 10.1016/j.jacc.2012.06.062. Epub 2012 Nov 14.

Myocardial recovery and the failing heart: myth, magic, or molecular target?

Douglas L Mann  1 , Philip M Barger, Daniel Burkhoff
Affiliations
Review

Myocardial recovery and the failing heart: myth, magic, or molecular target?

Douglas L Mann et al. J Am Coll Cardiol. .

Abstract

Medical and device therapies that reduce heart failure morbidity and mortality also lead to decreased left ventricular volume and mass and a more normal elliptical shape of the ventricle. These are due to changes in myocyte size, structure, and organization that have been referred to collectively as reverse remodeling. Moreover, there are subsets of patients whose hearts have undergone reverse remodeling either spontaneously or after medical or device therapies and whose clinical course is associated with freedom from future heart failure events. This phenomenon has been referred to as myocardial recovery. Despite the frequent interchangeable use of the terms "myocardial recovery" and "reverse remodeling" to describe the reversal of various aspects of the heart failure phenotype after medical and device therapy, the literature suggests that there are important differences between these 2 phenomena and that myocardial recovery and reverse remodeling are not synonymous. In this review, we discuss the biology of cardiac remodeling, cardiac reverse remodeling, and myocardial recovery with the intent to provide a conceptual framework for understanding myocardial recovery.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Reverse remodeling in clinical settings. Reverse remodeling is observed in a variety of clinical settings, as shown in the middle ring of the diagram. The segments illustrated in the outermost ring highlight the pathophysiological processes implicated by reverse remodeling in each particular clinical setting. (Abbreviations: ALM, acute lymphocytic myocarditis; CPAP, continuous positive airway pressure; RAAS, renin–angiotensin–aldosterone system; LVAD, left ventricular assist device; MVR, mitral valve repair/replacement; AVR, aortic valve replacement; CSD, cardiac support device; CRT, cardiac resynchronization therapy). (Adapted from Hellawell and Margulies(6) with permission)
Figure 2
Figure 2
Mechanical engineering science and cardiac remodeling. A) Diagram of a stress-strain curve of a ductile material, illustrating the relationship between an applied force (stress) and deformation (strain). Deformation can lead to reversible changes in a material (elastic deformation) if the properties of the material are not changed, and irreversible changes in a material (plastic deformation). B) Hypothetical model of reverse remodeling in heart that has undergone irreversible damage (plastic deformation). C) Hypothetical model of reverse remodeling with recovery in heart that has undergone reversible damage (elastic deformation).
Figure 3
Figure 3
Reverse remodeling and myocardial recovery. Cardiac remodeling arises secondary to abnormalities that arise in the biology of the cardiac myocyte (C), the myocardium (cardiocytes and extracellular matrix [M]), as well as LV geometry (LV), which have collectively been referred to as the heart failure phenotype. During reverse remodeling there is a reversal of the abnormalities in the cardiac myocyte, as well as the extracellular matrix, leading to a reversal of the abnormalities in LV geometry. Reverse remodeling can lead to two clinical outcomes (1) myocardial recovery, characterized by freedom from future cardiac events, or (2) myocardial remission, which is characterized by recurrence of heart failure events.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Kass DA, Baughman KL, Pak PH, et al. Reverse remodeling from cardiomyoplasty in human heart failure. External constraint versus active assist. Circulation. 1995;91:2314–8. - PubMed
    1. Levin HR, Oz MC, Chen JM, Packer M, Rose EA, Burkhoff D. Reversal of chronic ventricular dilation in patients with end-stage cardiomyopathy by prolonged mechanical unloading. Circulation. 1995;91:2717–20. - PubMed
    1. Westaby S, Jin XY, Katsumata T, Taggart DP, Coats AJ, Frazier OH. Mechanical Support in Dilated Cardiomyopathy: Signs of Early Left Ventricular Recovery (abstr) Ann Thorac Surg. 1997;64:1303–1308. - PubMed
    1. Cohn JN, Ferrari R, Sharpe N. Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. J Am Coll Cardiol. 2000;35:569–82. - PubMed
    1. Mann DL. Mechanisms and models in heart failure: a combinatorial approach. Circulation. 1999;100:999–1088. - PubMed

Publication types

MeSH terms